-
公开(公告)号:RS61408B1
公开(公告)日:2021-03-31
申请号:RSP20210129
申请日:2009-08-13
Applicant: VERTEX PHARMA
-
公开(公告)号:RS58604B1
公开(公告)日:2019-05-31
申请号:RSP20190432
申请日:2010-02-18
Applicant: VERTEX PHARMA
-
公开(公告)号:DK2464337T3
公开(公告)日:2019-04-23
申请号:DK10708442
申请日:2010-02-18
Applicant: VERTEX PHARMA
-
公开(公告)号:SI2328618T1
公开(公告)日:2018-04-30
申请号:SI200931803
申请日:2009-08-13
Applicant: VERTEX PHARMA
-
公开(公告)号:DK2328618T3
公开(公告)日:2018-02-19
申请号:DK09789125
申请日:2009-08-13
Applicant: VERTEX PHARMA
-
公开(公告)号:CY1115369T1
公开(公告)日:2017-01-04
申请号:CY141100558
申请日:2014-07-23
Applicant: VERTEX PHARMA
Inventor: BINCH HAYLEY , FANNING LEV T D , HURLEY DENNIS , SHETH URVI , SILINA ALINA , YANG XIAOQING , BOTFIELD MARTYN , GROOTENHUIS PETER D J , VAN GOOR FREDRICK , NUMA MEHDI MICHEL DJAMEL
IPC: A61K31/439 , C07D453/04 , C12Q1/02
Abstract: Ηπαρούσαεφεύρεσησχετίζεταιμετροποποιητέςτουρυθμιστήδιαμεμβρανικήςαγωγιμότηταςκυστικήςίνωσης ("CFTR"), συνθέσειςαυτώνκαιμεθόδουςμεαυτούς. Ηπαρούσαεφεύρεσηεπίσηςσχετίζεταιμεμεθόδουςθεραπείαςασθενειώνμεχρήσητροποποιητών CFΤR.
-
公开(公告)号:AU2016216569A1
公开(公告)日:2016-09-01
申请号:AU2016216569
申请日:2016-08-16
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER , DINEHART KIRK , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO , VERWIJS MARINUS JACOBUS
IPC: A61K47/32
Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3 carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
-
公开(公告)号:BR112012008082A2
公开(公告)日:2016-03-01
申请号:BR112012008082
申请日:2010-02-18
Applicant: VERTEX PHARMA
-
公开(公告)号:RS53460B
公开(公告)日:2014-12-31
申请号:RSP20140386
申请日:2009-10-23
Applicant: VERTEX PHARMA
Inventor: BINCH HAYLEY , FANNING LEV T D , HURLEY DENNIS , SHETH URVI , SILINA ALINA , YANG XIAOQING , BOTFIELD MARTYN , GROOTENHUIS PETER D J , VAN GOOR FREDRICK , NUMA MEHDI MICHEL DJAMEL
IPC: A61K31/439 , C07D453/04 , C12Q1/02
Abstract: The present invention relates to modulators of cystic fibrosis transmembrane conductance regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating diseases using modulators of CFTR.
-
公开(公告)号:ES2483690T3
公开(公告)日:2014-08-07
申请号:ES09822784
申请日:2009-10-23
Applicant: VERTEX PHARMA
Inventor: BINCH HAYLEY , FANNING LEV T D , HURLEY DENNIS , SHETH URVI , SILINA ALINA , YANG XIAOQING , BOTFIELD MARTYN , GROOTENHUIS PETER D J , VAN GOOR FREDRICK , NUMA MEHDI MICHEL DJAMEL
IPC: A61K31/439 , C07D453/04 , C12Q1/02
Abstract: Un compuesto de Fórmula (I): o sales farmacéuticamente aceptables del mismo, en la que: el anillo A se selecciona entre: en las que: R1 es -CF3, -CN o -C≡CCH2N(CH3)2; R2 es hidrógeno, -CH3, -CF3, -OH o -CH2OH; R3 es hidrógeno, -CH3, -OCH3 o -CN; con la condición de que tanto R2 como R3 no sean simultáneamente hidrógeno.
-
-
-
-
-
-
-
-
-